◀ Figure EV1 . VAPs modulate bouton maintenance and are associated with brain-enriched SCRN1 proteins.
◀ Figure EV2 . SCRN1 does not exhibit proteolytic activity and its C-terminal is recruited to VAP MSP domain.
A Schematic illustration of autolytic protease activation of C69 family members. B Sequence alignment of predicted proteolytic sites of SCRN family members according to the MEROPS database. C Western blot of lysates from HEK293T cells expressing BioGFP-SCRN1-WT, BioGFP-SCRN1-C9A, BioGFP-SCRN2-WT, BioGFP-SCRN2-C12A, BioGFP-SCRN3-WT, or BioGFP-SCRN3-C6A. Arrowheads represent (1) full-length BioGFP-SCRN proteins and (2) N-terminal cleaved BioGFP-SCRN2 and BioGFP-SCRN3. D Pull-down assay of HEK293T cells co-expressing Myc-VAPA with BioGFP, BioGFP-SCRN1-WT, BioGFP-SCRN1-C9A, BioGFP-SCRN1-N, or BioGFP-SCRN1-C. E Pull-down assay of HEK293T cells co-expressing Myc-VAPB with BioGFP, BioGFP-SCRN1-WT, BioGFP-SCRN1-C9A, BioGFP-SCRN1-N, or BioGFP-SCRN1-C. F Hippocampal neurons (DIV16) co-expressing HA-VAPB with GFP-SCRN1-N or GFP-SCRN1-C. Scale bars: 10 lm (full size) and 2 lm (zoom). G COS7 cells co-expressing GFP-SCRN1-C with HA-VAPA or HA-VAPB. Scale bars: 10 lm (full size) and 5 lm (zoom). H COS7 cells co-expressing HA-SCRN1 with GFP-VAPB-TM, GFP-VAPB-MSP-CC, or GFP-VAPB-MSP. Scale bars: 10 lm (full size) and 5 lm (zoom). I COS7 cells co-expressing GFP-SCRN1-N with HA-VAPA or HA-VAPB. Scale bars: 10 lm (full size) and 5 lm (zoom). A Schematic representation of the four potential FFAT-like motifs in SCRN1. Amino acid position number 2 (orange) of the FFAT-like motifs was mutated to alanine residues. B Quantifications of SCRN1 recruitment to VAPA-positive structures in COS7 cells (%) co-expressing HA-VAPA with GFP or GFP-SCRN1, GFP-SCRN1-N, GFP-SCRN1-C, GFP-SCRN1-Y40A, GFP-SCRN1-F144A, GFP-SCRN1-F153A, or GFP-SCRN1-F402A. N = 2-3, n = 39-59. C COS7 cells co-expressing HA-VAPA with GFP-SCRN1-Y40A, GFP-SCRN1-F144A, GFP-SCRN1-F153A, or GFP-SCRN1-F402A. Scale bars: 10 lm (full size) and 5 lm (zoom). D Hippocampal neurons (DIV16) co-expressing HA-VAPA with GFP-SCRN1-Y40A, GFP-SCRN1-F144A, GFP-SCRN1-F153A, or GFP-SCRN1-F402A. Scale bars: 10 lm (full size) and 5 lm (zoom).
Data information: ***P < 0.001, by chi-square test with post hoc analysis including Bonferroni correction.
▸ Figure EV4 . SCRN1 oligomerizes and regulates ER remodeling together with VAP.
A Quantifications of reticular localization of expressed VAPB in COS7 cells (%). Cells with non-reticular ER structures contained < 30% detectable ER tubules in cytoplasm. Gray bars represent non-reticular localization accompanied with impaired VAP-SCRN1 interaction. Left: co-expression GFP-SCRN1 with HA-VAPB or HA-VAPB-K87D/M89D (N = 2-3, n = 44-46). Right: co-expression of HA-VAPB with GFP or GFP-SCRN1, GFP-SCRN1-N, GFP-SCRN1-C, GFP-SCRN1-Y40A, GFP-SCRN1-F144A, GFP-SCRN1-F153A, or GFP-SCRN1-F402A (N = 2-3, n = 41-64). B Quantifications of reticular localization in COS7 cells (%) co-expressing HA-VAPA with GFP or GFP-SCRN1, GFP-SCRN1-N, GFP-SCRN1-C, GFP-SCRN1-Y40A, GFP-SCRN1-F144A, GFP-SCRN1-F153A, or GFP-SCRN1-F402A. Cells with non-reticular ER structures contained < 30% detectable ER tubules in cytoplasm. Gray bars represent non-reticular localization accompanied with impaired VAP-SCRN1 interaction. N = 2-3, n = 39-62 cells. C Quantifications of reticular localization of TagRFP-ER co-expressed with GFP, GFP-SCRN1, GFP-SCRN1-N, GFP-SCRN1-C, GFP-SCRN1-F402A, or GFP-SCRN1-C9A in COS7 cells. Gray bars represent non-reticular localization accompanied with impaired VAP-SCRN1 interaction. Cells with non-reticular ER structures contained < 30% detectable ER tubules in cytoplasm. N = 2-4, n = 58-120. D Live COS7 cells co-expressing TagRFP-ER with GFP, GFP-SCRN1, or GFP-SCRN1-F402A. Scale bars: 10 lm (full size) and 2 lm (zoom). E Pull-down assay of HEK293T cells co-expressing HA-SCRN1-N with BioGFP and BioGFP-SCRN1. 
